Susan Raiola is the President of Real Endpoints. Ms. Raiola has over 10 years of experience in the pharmaceutical consulting industry with a primary emphasis on reimbursement and market access. Ms. Raiola has consulted for both large and small pharmaceutical companies and has assisted with the commercial strategy for both new and inline products. Her experience ranges across multiple therapeutic areas including immunology, gastroenterology, cardiovascular, oncology (both solid and liquid), as well as orphan diseases. She enjoys collaborating with a range of functional teams to enhance product access and reimbursement and deliver maximum value to all key stakeholders. Ms. Raiola’s clients value her market access acumen and unparalleled customer service.

Ms. Raiola has developed several novel diagnostic assessments including Hub Excellence™, which optimizes the design of patient support programs based on competitor benchmarking, key stakeholder insights, and assessments of customer unmet needs & pain points. Ms. Raiola also developed RiQ™ (Reimbursement IQ) – a new model for measuring and enhancing reimbursement sales force effectiveness. Through both of these tools, Ms. Raiola and her team provide actionable insights and develop a tactical roadmap to maximize customers’ market access opportunities.

Ms. Raiola began her career as a financial analyst for Prudential, eventually managing a division responsible for individual insurance financial analysis and projections. She holds a BS in Finance, summa cum laude, from Seton Hall University. In 2019 she has recognized in PharmaVoice magazine as one of the 100 Most Inspiring Leaders in the Life Sciences.